Massimiliano Bianchi

Massimiliano Bianchi

Company: Ulysses Neuroscience

Job title: President & CEO

Seminars:

Translational Clinical & Preclinical Approaches to Advance Drug Discovery in Neuropsychiatric & Neurodevelopmental Disorders 11:55 am

 Patient-centric: The new role of patients in driving translational neuroscience research  Validation of molecular plasma biomarkers in major depression using post-mortem samples The INF-alpha model has as back-translational and neuroinflammation model of depression  The use of wireless and home recording EEG coupled with plasma biomarker in clinical trials Translational research in neurodevelopmental X-linked disorders: Fragile…Read more

day: Day One

Live Q&A 12:55 pm

Read more

day: Day One

Kick-off Panel Discussion: What is Preventing Experts from Redefining the Field & Developing Transformative Drugs for Psychiatric Patients in Need? 9:10 am

• Poor understanding of the disease biology for successful target selection • Heterogenous patient selection and low patient adherence • Animal models that lack translatability • Low precision of clinical endpoints • The need for more translatable biomarkers • Have we defined psychiatric disorders correctly yet? Download the event guide for full session details  Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.